A comprehensive view of Approved Drugs/Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves Rhythm Pharmaceuticals’ Imcivree setmelanotide injectable to treat obesity in patients with Bardet-Biedl syndrome; FDA did not approve drug for patients with Alstroem syndrome
Published: June 23, 2022 by SeeNews Pharmaceuticals
FDA approves Merck’s Vaxneuvance pneumococcal 15-valent conjugate vaccine for children ages 6 weeks to 17 years old; vaccine administered in four-dose series, provides superior immune response against pneumococcal serotype 3, unique serotypes 22F, 33F
Published: June 23, 2022 by Business Wire
NHTSA advises tire dealers, distributors that some utility terrain vehicle tires, ATV tires in US are incorrectly labeled with DOT mark; utility, ATV tires are not manufactured for use on public roadways, cannot be labeled with DOT symbol
Published: June 22, 2022 by Targeted News Service (Press Releases)
SI-BONE announces FDA clearance of iFuse-TORQ implant system for pelvic fracture fixation; 120,000 sacral fragility or insufficiency fractures occur annually in the US, with a 27% one-year mortality resulting from bedrest-associated complications
Published: June 22, 2022 by GlobeNewswire
FDA approves Lensar’s Ally Lensar cataract treatment system that combines femtosecond laser with phacoemulsification ultrasound technology; cataracts are world’s top cause of treatable blindness, cataract surgery most common surgical procedure in US
Published: June 21, 2022 by PR Web

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count